NP-001

N/A

Report date: 2025/01/20 20:00:37
NME

Base Information

Drug NameNP-001
Drug Alias NameNP-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsMacrophages modulators
TargetsNot applicable
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaAlzheimer Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesNeuvivo Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuvivo Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaHuntington Disease +[5] 
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A